{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:14:47Z","timestamp":1707524087773},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,25]]},"DOI":"10.7759\/cureus.10016","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T14:29:30Z","timestamp":1598365770000},"source":"Crossref","is-referenced-by-count":1,"title":["Frequency of Hepatorenal Syndrome Among Patients With Cirrhosis and Outcome After Treatment"],"prefix":"10.7759","author":[{"given":"Samina","family":"Fida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed Murtaza  S","family":"Khurshid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hala","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"Gracia-Sancho J","year":"2019","unstructured":"Gracia-Sancho J, Marrone G, Fern\u00e1ndez-Iglesias A. Hepatic microcirculation and mechanisms of portal hypertension. Nat Rev Gastroenterol Hepatol. 2019, 16:221-234. 10.1038\/s41575-018-0097-3","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5945","article-title":"Assessment of knowledge about the risk Factors of chronic liver disease in patients admitted in Civil Hospital Karachi","volume":"11","author":"Majid B","year":"2019","unstructured":"Majid B, Khan R, Junaid Z, et al.. Assessment of knowledge about the risk Factors of chronic liver disease in patients admitted in Civil Hospital Karachi. Cureus. 2019, 11:5945. 10.7759\/cureus.5945","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2018.10.002","article-title":"Epidemiology, pathophysiology, and management of hepatorenal syndrome","volume":"39","author":"Amin AA","year":"2019","unstructured":"Amin AA, Alabsawy EI, Jalan R, Davenport A. Epidemiology, pathophysiology, and management of hepatorenal syndrome. Semin Nephrol. 2019, 39:17-30. 10.1016\/j.semnephrol.2018.10.002","journal-title":"Semin Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.50.1.111","article-title":"Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure","volume":"50","author":"Anand R","year":"2002","unstructured":"Anand R, Harry D, Holt  S, et al.. Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure. Gut. 2002, 50:111-117. 10.1136\/gut.50.1.111","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.nephro.2013.11.005","article-title":"Syndrome h\u00e9pator\u00e9nal [Hepatorenal syndrome]","volume":"10","author":"Pillebout E","year":"2014","unstructured":"Pillebout E. Syndrome h\u00e9pator\u00e9nal [Hepatorenal syndrome]. Nephrol Ther. 2014, 10:61-8. 10.1016\/j.nephro.2013.11.005","journal-title":"Nephrol Ther"},{"key":"ref6","article-title":"[Hepato-renal syndrome]","volume":"34","author":"Di Lullo L","year":"2017","unstructured":"Di Lullo L, Ronco C, Barbera V, Santoboni F, Bellasi A. [Hepato-renal syndrome]. G Ital Nefrol. 2017, 34:178-187.","journal-title":"G Ital Nefrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30478","article-title":"Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver","volume":"69","author":"Lee BP","year":"2019","unstructured":"Lee BP, Vittinghoff E, Hsu C, et al.. Predicting low risk for sustained alcohol use after early liver transplant for acute alcoholic hepatitis: the sustained alcohol use post-liver. Hepatology. 2019, 69:1477-1487. 10.1002\/hep.30478","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2016.05.009","article-title":"Hepatorenal syndrome","volume":"62","author":"Shah N","year":"2016","unstructured":"Shah N, Silva RG, Kowalski A, Desai C, Lerma E. Hepatorenal syndrome. Dis Mon. 2016, 62:364-375. 10.1016\/j.disamonth.2016.05.009","journal-title":"Dis Mon"},{"key":"ref9","article-title":"Hepatorenal syndrome","volume":"28","author":"Ng CK","year":"2007","unstructured":"Ng CK, Chan MH, Tai MH, Lam CW. Hepatorenal syndrome. Clin Biochem Rev. 2007, 28:11-17.","journal-title":"Clin Biochem Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-017-9815-0","article-title":"Management of ascites and hepatorenal syndrome","volume":"12","author":"Piano S","year":"2018","unstructured":"Piano S, Tonon M, Angeli P. Management of ascites and hepatorenal syndrome. Hepatol Int. 2018, 12:122-134. 10.1007\/s12072-017-9815-0","journal-title":"Hepatol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619825719","article-title":"Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2","volume":"7","author":"Nguyen-Tat M","year":"2019","unstructured":"Nguyen-Tat M, J\u00e4ger J, Rey JW, et al.. Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2. United European Gastroenterol J. 2019, 7:529-537. 10.1177\/2050640619825719","journal-title":"United European Gastroenterol J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000913","article-title":"Pharmacological therapies for hepatorenal syndrome: a systematic review and meta-analysis","volume":"52","author":"Nanda A","year":"2018","unstructured":"Nanda A, Reddy R, Safraz H, Salameh H, Singal AK. Pharmacological therapies for hepatorenal syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2018, 52:360-367. 10.1097\/MCG.0000000000000913","journal-title":"J Clin Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1053\/he.2000.5852","article-title":"A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts","volume":"31","author":"Malinchoc M","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000, 31:864-871. 10.1053\/he.2000.5852","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2008.06.019","article-title":"Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors","volume":"13","author":"Ali SA","year":"2009","unstructured":"Ali SA, Donahue RM, Qureshi H, Vermund SH. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009, 13:9-19. 10.1016\/j.ijid.2008.06.019","journal-title":"Int J Infect Dis"},{"key":"ref15","article-title":"Hepatorenal syndrome in patients with cirrhosis of liver according to 2007 International Ascites Club Criteria","volume":"28","author":"Seetlani NK","year":"2016","unstructured":"Seetlani NK, Memon AR, Iftikhar F, Ali A, Fazel PA. Hepatorenal syndrome in patients with cirrhosis of liver according to 2007 International Ascites Club Criteria. J Ayub Med Coll Abbottabad. 2016, 28:578-581.","journal-title":"J Ayub Med Coll Abbottabad"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90031-7","article-title":"Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites","volume":"105","author":"Gin\u00e8s A","year":"1993","unstructured":"Gin\u00e8s A, Escorsell A, Gin\u00e8s P, et al.. Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology. 1993, 105:229-236. 10.1016\/0016-5085(93)90031-7","journal-title":"Gastroenterology"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2010.03.029","article-title":"Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites","volume":"8","author":"Montoliu S","year":"2010","unstructured":"Montoliu S, Ballest\u00e9 B, Planas R, et al.. Incidence and prognosis of different types of functional renal failure in cirrhotic patients with ascites. Clin Gastroenterol Hepatol. 2010, 8:616-622. 10.1016\/j.cgh.2010.03.029","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.03.012","article-title":"Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice","volume":"55","author":"Salerno F","year":"2011","unstructured":"Salerno F, Cazzaniga M, Merli M, et al..  Diagnosis, treatment and survival of patients with hepatorenal syndrome: a survey on daily medical practice. J Hepatol. 2011, 55:1241-1248. 10.1016\/j.jhep.2011.03.012","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/207012","article-title":"Hepatorenal syndrome: aetiology, diagnosis, and treatment","volume":"2015","author":"Low G","year":"2015","unstructured":"Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: aetiology, diagnosis, and treatment. Gastroenterol Res Pract. 2015, 2015:207012. 10.1155\/2015\/207012","journal-title":"Gastroenterol Res Pract"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2019.06.002","article-title":"Ascites and hepatorenal syndrome","volume":"23","author":"Adebayo D","year":"2019","unstructured":"Adebayo D, Neong SF, Wong F. Ascites and hepatorenal syndrome. Clin Liver Dis. 2019, 23:659-682. 10.1016\/j.cld.2019.06.002","journal-title":"Clin Liver Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis","volume":"33","author":"Gonwa TA","year":"2012","unstructured":"Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012, 33:144-148. 10.1159\/000334149","journal-title":"Blood Purif"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi212","article-title":"The course of type 1 hepato-renal syndrome post liver transplantation","volume":"21","author":"Marik","year":"2006","unstructured":"Marik, PE, Wood, K, Starzl, TE. The course of type 1 hepato-renal syndrome post liver transplantation. Nephrol Dial Transplant. 2006, 21:478-482. 10.1093\/ndt\/gfi212","journal-title":"Nephrol Dial Transplant"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2174\/138161206779010413","article-title":"Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis","volume":"12","author":"Schmidt LE","year":"2006","unstructured":"Schmidt LE, Ring-Larsen H. Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosis. Curr Pharm Des. 2006, 12:4637-4647. 10.2174\/138161206779010413","journal-title":"Curr Pharm Des"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010431","article-title":"Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"97","author":"Wang H","year":"2018","unstructured":"Wang H, Liu A, Bo W, Feng X, Hu Y. Terlipressin in the treatment of hepatorenal syndrome: a systematic review and meta-analysis. Medicine (Baltimore). 2018, 97:0431. 10.1097\/MD.0000000000010431","journal-title":"Medicine (Baltimore)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1159\/000084725","article-title":"Hepatorenal syndrome","volume":"37","author":"Guevara M","year":"2005","unstructured":"Guevara M, Gin\u00e8s P. Hepatorenal syndrome. Int J Biochem Cell Biol. 2005, 37:22-26. 10.1159\/000084725","journal-title":"Int J Biochem Cell Biol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20262","article-title":"Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome","volume":"40","author":"Wong F","year":"2004","unstructured":"Wong F, Pantea L, Sniderman K. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome. Hepatology. 2004, 40:55-64. 10.1002\/hep.20262","journal-title":"Hepatology"},{"key":"ref27","article-title":"Emerging indications for albumin dialysis","volume":"100","author":"Sen S","year":"2005","unstructured":"Sen S, Williams R, Jalan R. Emerging indications for albumin dialysis. Am J Gastroenterol. 2005, 100:468-475.","journal-title":"Am J Gastroenterol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2015.094","article-title":"Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis","volume":"32","author":"Chang KY","year":"2017","unstructured":"Chang KY, Kim HW, Jin DC, Kim YS. Ascites reinfusion dialysis of refractory ascites as a bridge to kidney and liver transplantation in a patient on hemodialysis. Korean J Intern Med. 2017, 32:363-364. 10.3904\/kjim.2015.094","journal-title":"Korean J Intern Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2016.48","article-title":"Updates on hepatorenal syndrome and strategies bridging to liver transplantation","volume":"3","author":"Cheung CY","year":"2017","unstructured":"Cheung CY, Chok KSH. Updates on hepatorenal syndrome and strategies bridging to liver transplantation. Hepatoma Res. 2017, 3:67-72. 10.20517\/2394-5079.2016.48","journal-title":"Hepatoma Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/39160-frequency-of-hepatorenal-syndrome-among-patients-with-cirrhosis-and-outcome-after-treatment","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:24:19Z","timestamp":1707506659000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/39160-frequency-of-hepatorenal-syndrome-among-patients-with-cirrhosis-and-outcome-after-treatment"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.10016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,25]]}}}